These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35874637)

  • 21. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
    J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786).
    Vigneault E; Morton G; Parulekar WR; Niazi TM; Springer CW; Barkati M; Chung P; Koll W; Kamran A; Monreal M; Ding K; Loblaw A
    Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):527-533. PubMed ID: 29903505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation.
    Jereczek-Fossa BA; Zerini D; Fodor C; Santoro L; Cambria R; Garibaldi C; Tagaste B; Vavassori A; Cattani F; Alterio D; Gherardi F; Serafini F; Rocco B; Musi G; De Cobelli O; Orecchia R
    Urol Oncol; 2011; 29(5):523-32. PubMed ID: 20005749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of image-guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy.
    Liang JA; Tu CY; Hsia TC; Fang HY; Li CC; Chien CR
    Thorac Cancer; 2020 Sep; 11(9):2639-2649. PubMed ID: 32725779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term clinical outcomes of lipiodol marking using standard gastroscopy for image-guided radiotherapy of upper gastrointestinal cancers.
    Be KH; Khor R; Lim Joon D; Starvaggi B; Chao M; Ng SP; Ng M; Zorron Cheng Tao Pu L; Efthymiou M; Vaughan R; Chandran S
    World J Gastroenterol; 2021 Nov; 27(42):7387-7401. PubMed ID: 34876797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Shenqi Fuzheng Injection on Leukopenia and T-cell Subsets in Patients with Non-small Cell Lung Cancer Undergoing Radiotherapy.
    Wu C; Liang Y; Fu F
    Evid Based Complement Alternat Med; 2022; 2022():2832739. PubMed ID: 35966722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial.
    Wang D; Zhang Q; Eisenberg BL; Kane JM; Li XA; Lucas D; Petersen IA; DeLaney TF; Freeman CR; Finkelstein SE; Hitchcock YJ; Bedi M; Singh AK; Dundas G; Kirsch DG
    J Clin Oncol; 2015 Jul; 33(20):2231-8. PubMed ID: 25667281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Huang YJ; Chanchien CC; Lin H; Wang CJ; Sun LM; Tseng CW; Tsai CC; Ou YC; Fu HC; Chen HC; Hsu HC; Wang CY
    Radiat Oncol; 2012 Jan; 7():13. PubMed ID: 22289572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Usefulness of (18)F-FDG PET/CT in the Detection of Early Recurrence in Treated Cervical Cancer Patients with Unexplained Elevation of Serum Tumor Markers.
    Chong A; Ha JM; Jeong SY; Song HC; Min JJ; Bom HS; Choi HS
    Chonnam Med J; 2013 Apr; 49(1):20-6. PubMed ID: 23678473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma.
    Gadducci A; Ferdeghini M; Prontera C; Giordano P; Cristofani R; Bianchi R; Fioretti P
    Eur J Gynaecol Oncol; 1990; 11(4):283-8. PubMed ID: 2245812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
    Chmura A; Wojcieszek A; Mrochem J; Walaszek-Gruszka A; Deja R; Masłyk B; Bartnik W; Sodowski K
    Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of therapy for advanced hepatocellular carcinoma: intra-arterial 5-fluorouracil and subcutaneous interferon with image-guided radiation.
    Chuma M; Taguchi H; Yamamoto Y; Shimizu S; Nakanishi M; Ogawa K; Sho T; Horimoto H; Kobayashi T; Nakai M; Terashita K; Sakuhara Y; Abo D; Tsukuda Y; Tsunematsu S; Hige S; Kato M; Shirato H; Asaka M
    J Gastroenterol Hepatol; 2011 Jul; 26(7):1123-32. PubMed ID: 21501224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels and positive rates of tumor biomarkers in oral precancer patients.
    Wu YH; Lin PY; Yang JH; Kuo YS; Wu YC
    J Formos Med Assoc; 2021 Jun; 120(6):1324-1331. PubMed ID: 33581964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.
    Vesprini D; Catton C; Jacks L; Lockwood G; Rosewall T; Bayley A; Chung P; Gospodarowicz M; Ménard C; Milosevic M; Nichol A; Skala M; Warde P; Bristow RG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):608-16. PubMed ID: 22099034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice.
    Shimura K; Mabuchi S; Yokoi T; Sasano T; Sawada K; Hamasaki T; Kimura T
    J Gynecol Oncol; 2013 Oct; 24(4):321-9. PubMed ID: 24167667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IGRT versus non-IGRT for postoperative head-and-neck IMRT patients: dosimetric consequences arising from a PTV margin reduction.
    Schwarz M; Giske K; Stoll A; Nill S; Huber PE; Debus J; Bendl R; Stoiber EM
    Radiat Oncol; 2012 Aug; 7():133. PubMed ID: 22873744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Diagnostic Value of Carcinoembryonic Antigen and Squamous Cell Carcinoma Antigen in Lung Adenosquamous Carcinoma.
    Jin X; Xu X; Xu H; Lv L; Lu H
    Clin Lab; 2017 Apr; 63(4):801-808. PubMed ID: 28397462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.